Table 2.
Antibiotic Practices for Fistula Surgery
| N | % | |
|---|---|---|
| Antibiotics usually available for pelvic surgery * | ||
| Aminoglycosides (e.g., gentamicin/tobramycin) | 31 | 78% |
| Quinolones (e.g., ciprofloxacin) | 31 | 78% |
| Second-generation cephalosporins (e.g., cefuroxime) | 15 | 38% |
| Third-generation cephalosporins (e.g., ceftriaxone) | 22 | 55% |
| "Rescue" antibiotics for multi-resistant organisms (e.g., imipenem) | 2 | 5% |
| Factors influencing availability of antibiotics^ | ||
| Market factors: drug availability and hospital budget | 12 | 30% |
| Hospital formulary set by administration | 11 | 28% |
| Ministry of Health's essential drug list | 8 | 20% |
| Donation from partners | 4 | 10% |
| Other | 4 | 10% |
| No response | 1 | 3% |
| Use of prophylactic antibiotics^ | ||
| For every fistula case | 23 | 58% |
| For selected fistula cases | 14 | 35% |
| Never | 2 | 5% |
| No response | 1 | 3% |
| Most important factor in choice of prophylactic antibiotics^ | ||
| Recommendations of medical literature | 9 | 23% |
| Surgeon training in vesicovaginal fistula surgery | 9 | 23% |
| Availability | 7 | 18% |
| Personal choice | 5 | 13% |
| Cost | 2 | 5% |
| Does not use prophylactic antibiotics | 1 | 3% |
| Other | 7 | 18% |
* Multiple responses allowed; percentages exceed 100%.
^ Exceeds 100% due to rounding.